Re: Bad timing.
I think it might be our obvious need to raise money.
We had 416M at the end of the year.
We’ll owe Neuren $40M with the first sell.
We have the marketing and manufacturing costs.
It could be the thought that insurers may balk at the $375,000 pricing?
Most of us thought we’d be taking some profits today.